Macrogenics (NASDAQ: MGNX) reported Q1 EPS of ($0.84), $0.20 worse than the analyst estimate of ($0.64). Revenue for the quarter came in at $9.1 million versus the consensus estimate of $14.86 million.

For earnings history and earnings-related data on Macrogenics (MGNX) click here.